Show simple item record

dc.contributor.authorKernaghan, S
dc.contributor.authorMoretti, L
dc.contributor.authorKilburn, L
dc.contributor.authorWilkinson, K
dc.contributor.authorSnowdon, C
dc.contributor.authorMorden, J
dc.contributor.authorMacpherson, I
dc.contributor.authorWardley, Andrew M
dc.contributor.authorRoylance, R
dc.contributor.authorBaird, R
dc.contributor.authorRing, A
dc.contributor.authorTurner, N
dc.contributor.authorBliss, JM
dc.date.accessioned2019-12-09T17:08:17Z
dc.date.available2019-12-09T17:08:17Z
dc.date.issued2019en
dc.identifier.citationKernaghan S, Moretti L, Kilburn L, Wilkinson K, Snowdon C, Morden J, et al. The UK plasma based molecular profiling of advanced breast cancer to inform therapeutic choices (plasmaMATCH) Trial: a multiple parallel-cohort, phase IIa platform trial aiming to provide proof of principle efficacy for designated targeted therapies in patient subgroups identified through ctDNA screening (CRUK/15/010). Trials. 2019;20(Suppl 1)en
dc.identifier.urihttp://hdl.handle.net/10541/622550
dc.language.isoenen
dc.titleThe UK plasma based molecular profiling of advanced breast cancer to inform therapeutic choices (plasmaMATCH) Trial: a multiple parallel-cohort, phase IIa platform trial aiming to provide proof of principle efficacy for designated targeted therapies in patient subgroups identified through ctDNA screening (CRUK/15/010)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentClinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU), United Kingdomen
dc.identifier.journalTrialsen
dc.description.noteen


This item appears in the following Collection(s)

Show simple item record